Kevin N. Dietz Ph.D.

Prior to joining Baker Donelson, Dr. Dietz was with the Office of Technology Management at LSU Health Sciences Center, New Orleans, where he focused on technology evaluation and marketing, patentability assessment, and management of patent portfolios. Earlier in his career, he completed a joint postdoctoral fellowship in the Department of Neurology at Harvard Medical School and the Center for Human Genetic Research at Massachusetts General Hospital, where he studied the role of epigenetic modifications in Huntington's disease in the laboratory of Dr. James Gusella. Dr. Dietz earned his undergraduate degree in Biology from Louisiana State University and his Ph.D. in Genetics from LSU Health Sciences Center-New Orleans. He is the author or co-author of several scientific publications and conference presentations..

Dr. Dietz completed a joint post-doctoral fellowship in the Department of Neurology at Harvard Medical School and the Center for Human Genetic Research at Massachusetts General Hospital, where he investigated the role of epigenetic modifications in Huntington's disease in the laboratory of Dr. James Gusella. He graduated from Louisiana State University with an undergraduate degree in Biology, and received a Ph.D. in Genetics from the LSU Health Sciences Center.

Dr. Dietz's technical skills encompass genetics, biochemistry, molecular biology, and cell biology. The author and co-author of several publications, he has also presented both oral presentations and posters at scientific meetings and conferences.

• Member – Association of University Technology Managers
• Recipient – 2015 AUTM Volunteer Service Award, Western Hemisphere

• Protein- or peptide-based technologies, including antibodies and antibody engineering, bispecific and multispecific antibodies, and chimeric antigen receptors (CARs) technology
• Immunotherapies, including vaccines such as peptide vaccines or mRNA vaccine technology
• Cell-based technologies, including genetically engineered cells, stem cell technologies, cell-based antibody production, cell culture systems, and related medias
• Gene therapy and RNA-based therapeutics
• Methods of treatment, including synergistic combination therapies, such as for cancer, neurodegenerative diseases, infectious diseases, ocular diseases, and inflammation
• Diagnostic and/or prognostic methods, including assays
• Agricultural-based technologies, including botanical compositions
• Drug-screening methods, including in vitro and in vivo model systems

• "SUCCESS Act Extends USPTO's Fee-Setting Authority," IAM Weekly International Report (December 2018)
• "Tribal Sovereign Immunity Does Not Apply to PTAB Proceedings," IAM Weekly International Report (March 2018)
• "Potential Shift in Landscape of University IP Management," IAM Weekly International Report (December 2017)
• "When Big Brother Comes Marching In: Patent Challenges on Entrepreneurial Campuses," IPWatchdog® (November 2017)
• Lead Author – "Public Universities are Immune from Inter Partes Review, but are Their Patent Co-Owners?," IAM Weekly International Report (August 2017)
• Lead Author – "Is it time to reform 35 USC Section 101?," IAM Weekly International Report (June 2017)
• Lead Author – "PTAB: Public Universities Immune to Inter Partes Review," IAM Weekly International Report (April 2017)
• Lead Author – "The Federal Government's March-In Right: What Does it Mean for Your Intellectual Property?," IAM Weekly International Report (December 2016)
• Lead Author – "USPTO Requests Public Comment on Proposed Fee Adjustments," IAM Weekly International Report (October 2016)
• Lead Author – "The Drosophila Huntington's disease gene ortholog dhtt influences chromatin regulation during development," Human Molecular Genetics (January 2015)
• Lead Author – "Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation," International Journal of Biochemistry & Cell Biology (June 2011)

• "IP Basics for Biotech," Nucleate, New Orleans (January 2026)
• "Intellectual Property – Inventorship, Ownership, and Tips to Avoid Common Mistakes," LSU Health Shreveport (June 2025)
• "Intellectual Property – A Building Block to a Successful Business," Idea Village, New Orleans (October 2024)
• "Intellectual Property – A Building Block to a Successful Business," Loyola University – New Orleans, LaunchU (May 2023)
• "Technology Commercialization: A Synergy Between Science, Business and Law," LSU Health – New Orleans (April 2023)
• "So You Think You Can Patent That – Answers to Frequently Asked Questions for Gene-Based and Other Life Science Technologies," LSU Health – Shreveport (October 2022)
• "Intellectual Property – A Building Block to a Successful Business," Arkansas State University (November 2021; April 2022; May 2022)
• "The Road to Patent Protection," LSU Health – Shreveport (March 2022)
• Panelist – "Get the 411 on a Gig in Tech Transfer," 2019 AUTM Annual Meeting, Austin, Texas (February 2019)
• Moderator – "New to Tech Transfer?," 2019 AUTM Annual Meeting, Austin, Texas (February 2019)
• "§101 Woes and Solution," Dana-Farber Cancer Institute, Boston, Massachusetts (November 2018)
• "Intellectual Property: A Building Block to a Successful Business," Arkansas State University, Jonesboro, Arkansas (November 2018)
• "Technology Commercialization: A synergy between Science, Business and Law," LSU Health Sciences Center (April 2018)
• Responsible Conduct of Research Seminar on Intellectual Property, Pennington Biomedical Research Center (April 2018)
• Moderator – "New to Tech Transfer?," 2018 AUTM Annual Meeting, Phoenix, Arizona (February 2018)
• Moderator – Biotech & Cannabis Industry Panel, Turnaround Management Association of Louisiana (November 2017)
• "Partnering with Universities and Industry," 2017 Louisiana Life Sciences and Technology Symposium, New Orleans, Louisiana (September 2017)
• Moderator – "New to Tech Transfer?," 2017 AUTM Annual Meeting, Hollywood, Florida (March 2017)
• "Critical Issues in Licensing University Technologies," New Orleans BioInnovation Center (August 2016)
• "University Patent Applications: To Be or Not To Be…a 'Micro Entity'," Network of Technology Transfer Professionals of Louisiana (NTTPL) (July 2016)